Association between n - 4 - hydroxy - 2 - {2 - (n, N - dimetilaminometil benzofuran) ethoxy - 2 - ilcarbonilamino} benzamide and Cisplatin in nasopharyngeal carcinoma

摘要

N - 4 - hydroxy - 2 - {[2 - (n, N - dimetilaminometil benzofuran) ethoxy] - 2 - ilcarbonilamino} benzamide of formula (1) or one of its Salts addition to a pharmaceutically acceptable acid or a base, in association with chemotherapy or radiotherapy for use in the treatment of L carcinoma of nasopharynx. Medicines.